PYCPHYLOGICA ACHIEVES MILESTONE IN PHARMA COLLABORATION WITH...

PYC

PHYLOGICA ACHIEVES MILESTONE IN PHARMA COLLABORATION WITH JANSSEN

PERTH, AUSTRALIA: January 31, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the extension of its collaboration with Janssen Biotech, Inc. and its affiliates (“Janssen”) to discover, develop and commercialise new classes of peptide-drug conjugates derived from Phylogica’s Phylomer®
drug discovery platform. Phylogica has received an undisclosed payment for funding additional research associated with the extension of the collaboration.